VMP 42131611000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Lorazepam 2.5mg tablets
BNF code 0401020P0AAACAC
Virtual Therapeutic Moiety Lorazepam
Date identifier became valid 4 Aug 2023
Previous product identifier 321295009
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Lorazepam
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 2.500
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category Schedule 4 (CD Benz)
Actual Medicinal Products
Lorazepam 2.5mg tablets (A A H Pharmaceuticals Ltd)
Lorazepam 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Lorazepam 2.5mg tablets (Almus Pharmaceuticals Ltd)
Lorazepam 2.5mg tablets (Aristo Pharma Ltd)
Lorazepam 2.5mg tablets (Genesis Pharmaceuticals Ltd)
Lorazepam 2.5mg tablets (Genus Pharmaceuticals Holdings Ltd)
Lorazepam 2.5mg tablets (Medihealth (Northern) Ltd)
Lorazepam 2.5mg tablets (Morningside Healthcare Ltd)
Lorazepam 2.5mg tablets (Phoenix Healthcare Distribution Ltd)
Lorazepam 2.5mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Lorazepam 2.5mg tablets 28 tablet
Lorazepam 2.5mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback